Decipher Prostate Genomic Classifier Results are Linked to Real-World Data in SEER Specialized Database Release
Decipher Prostate Genomic Classifier data is included in a new SEER Program database, enabling the study of prostate cancer outcomes.
Category: Prostate
Prostate
Latest
Prostate
Latest
Prostate Cancer: Is AI the Answer to Limit Need of Biopsies?
A retrospective study shows that combining risk markers, MRI evaluation, and AI can more accurately predict prostate cancer risk.
Prostate
Latest
Blood Test and MRI Combo Could Reduce Unnecessary Prostate Biopsies
MRI of the prostate, combined with a blood test, can help find if a prostate lesion is clinically significant cancer, new research suggests.
ArteraAI Gets Medicare Payment Rate for Prostate Cancer Test
ArteraAI says the CMS decided on the payment rate for the ArteraAI Prostate Test, a clinical diagnostic laboratory test for prostate cancer.
Read More
$3M Grant to Develop AI to Detect Aggressive Prostate Cancer
UCLA Researchers have received a five-year, $3 million grant to develop AI that can detect and predict aggressive prostate cancer.
Read More
Biomarker HSD3B1 Identified as Reason for Therapeutic Resistance
Men with biomarker HSD3B1 may exhibit resistance to combined radiation and hormone therapy for prostate cancer.Â
Read More
Black Men are More Likely to Have Prostate Cancer than White Men
Black men are more likely to develop prostate cancer than white men and more likely to have advanced disease and to die than white men.Â
Read More
ArteraAI Validates Prognostic Model in Advanced Prostate Cancer
ArteraAI will present data demonstrating the successful validation of its prognostic model in advanced prostate cancer.
Read More
New Algorithm Predicts Prostate Cancer Recurrence for Radiation Therapy Patients
Researchers developed a patent-pending method and algorithm to predict prostate cancer recurrence in patients treated by radiation therapy.Â
Read More
Precision Medicine Navigators Increase Genomic Testing Rates for Black Patients with Prostate Cancer
Black patients seen by a precision medicine navigator were substantially more likely to receive genomic testing than those who were not.
Read More
Detecting Metastatic Prostate Cancer Risk in Black Men
To explore why prostate cancer disproportionately harms Black men, researchers looked to another disorder, diabetes, which alters metabolism.
Read More
Researcher Leads Development of Urine Test for Prostate Cancer Detection
Biomarkers of significant prostate cancer that are detected in urine or blood tests are desperately needed to help reduce prostate biopsies.
Read More
How Veracyte’s Prostate Genomic Classifier Guides Cancer Treatment
A new study demonstrated Decipher Prostate Genomic Classifier’s ability to guide personalized treatment for men with prostate cancer.Â
Read More
Quest Launches Prostate Cancer Test to Improve Diagnosis and Grading
Quest launched a prostate cancer biomarker test through its pathology business, AmeriPath, in collaboration with Envision Sciences.Â
Read More
AI Model IDs Patients to Best Benefit from ADT for Prostate Cancer Treatment
The AI-based predictive model was able to identify patients with a predominantly intermediate risk for prostate cancer likely to benefit from short-term ADT.
Read More
Cleveland Diagnostics’ New Facility will Feature IsoPSAÂ Testing
Cleveland Diagnostics, a biotechnology company developing next-gen diagnostic tests for early detection of cancers, opened a new facility.
Read More
American Indian, Alaska Native Men Less Likely to Get Prostate Cancer Screening
American Indian and Alaska Native men also experience disproportionately greater prostate cancer mortality compared to other racial/ethnic identities.
Read More
Personalizing Prostate Cancer Screening May Improve Detection Accuracy
The accuracy of PSA in prostate cancer screening can be improved by accounting for genetic factors that are not associated with cancer.
Read More